|
UBE3C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.866200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.991000E-01 |
| Normal-vs-Stage2 |
6.100200E-01 |
| Normal-vs-Stage3 |
9.703600E-01 |
| Normal-vs-Stage4 |
4.658000E-01 |
| Stage1-vs-Stage2 |
6.878800E-01 |
| Stage1-vs-Stage3 |
9.222400E-01 |
| Stage1-vs-Stage4 |
5.731000E-01 |
| Stage2-vs-Stage3 |
6.692000E-01 |
| Stage2-vs-Stage4 |
3.976400E-01 |
| Stage3-vs-Stage4 |
6.190200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.197800E-01 |
| Normal-vs-AfricanAmerican |
5.347800E-01 |
| Normal-vs-Asian |
3.895000E-01 |
| Caucasian-vs-AfricanAmerican |
8.071000E-01 |
| Caucasian-vs-Asian |
4.084800E-01 |
| AfricanAmerican-vs-Asian |
3.231200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.540000E-01 |
| Normal-vs-Female |
1.620190E-01 |
| Male-vs-Female |
3.062200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.465600E-01 |
| Normal-vs-Extreme_Weight |
9.204400E-01 |
| Normal-vs-Obese |
3.530600E-01 |
| Normal-vs-Extreme_Obese |
6.074600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.755800E-01 |
| Normal_Weight-vs-Obese |
2.358800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.052400E-01 |
| Extreme_Weight-vs-Obese |
4.315200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.642800E-01 |
| Obese-vs-Extreme_Obese |
7.771400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.867600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.096620E-01 |
| Normal-vs-Age(61-80Yrs) |
7.961600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.441600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.574200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.556600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.704100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.030020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.422030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.108400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.469900E-02 |
| Normal-VS-Type2 PRCC |
7.658000E-02 |
| Normal-VS-KIRP CIMP |
8.504100E-02 |
| Normal-VS-Unclassified PRCC |
4.540200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.697000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.900200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.885400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.523690E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.137700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.719000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.844300E-02 |
| Normal-vs-N1 |
9.537800E-01 |
| Normal-vs-N2 |
9.227400E-01 |
| N0-vs-N1 |
1.360160E-01 |
| N0-vs-N2 |
5.225200E-01 |
| N1-vs-N2 |
9.130000E-01 |
|
|
